These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21753781)

  • 1. Expression and function of the kallikrein-related peptidase 6 in the human melanoma microenvironment.
    Krenzer S; Peterziel H; Mauch C; Blaber SI; Blaber M; Angel P; Hess J
    J Invest Dermatol; 2011 Nov; 131(11):2281-8. PubMed ID: 21753781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KLK6/PAR1 Axis Promotes Tumor Growth and Metastasis by Regulating Cross-Talk between Tumor Cells and Macrophages.
    Hwang YS; Cho HJ; Park ES; Lim J; Yoon HR; Kim JT; Yoon SR; Jung H; Choe YK; Kim YH; Lee CH; Kwon YT; Kim BY; Lee HG
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential roles of kallikrein-related peptidase 6 in malignant transformation and ΔNp63β-mediated epithelial-mesenchymal transition of oral squamous cell carcinoma.
    Kaneko N; Kawano S; Yasuda K; Hashiguchi Y; Sakamoto T; Matsubara R; Goto Y; Jinno T; Maruse Y; Morioka M; Hattori T; Tanaka S; Tanaka H; Kiyoshima T; Nakamura S
    Oral Oncol; 2017 Dec; 75():148-157. PubMed ID: 29224812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic expression of KLK6 in MDA-MB-435 melanoma cells reduces tumorigenicity in vivo.
    Pampalakis G; Zingkou E; Zoumpourlis V; Sotiropoulou G
    Pathol Res Pract; 2021 Jan; 217():153276. PubMed ID: 33249398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Kallikrein-Related Peptidase 6 in Primary Mucosal Malignant Melanoma of the Head and Neck.
    Thierauf J; Veit JA; Lennerz JK; Weissinger SE; Affolter A; Döscher J; Bergmann C; Knopf A; Grünow J; Grünmüller L; Mauch C; Plinkert PK; Hoffmann TK; Hess J
    Head Neck Pathol; 2017 Sep; 11(3):314-320. PubMed ID: 27844409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of kallikrein-related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion.
    Delaunay T; Deschamps L; Haddada M; Walker F; Soosaipillai A; Soualmia F; El Amri C; Diamandis EP; Brattsand M; Magdolen V; Darmoul D
    Mol Oncol; 2017 Oct; 11(10):1330-1347. PubMed ID: 28636767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KLK6 expression in skin induces PAR1-mediated psoriasiform dermatitis and inflammatory joint disease.
    Billi AC; Ludwig JE; Fritz Y; Rozic R; Swindell WR; Tsoi LC; Gruzska D; Abdollahi-Roodsaz S; Xing X; Diaconu D; Uppala R; Camhi MI; Klenotic PA; Sarkar MK; Husni ME; Scher JU; McDonald C; Kahlenberg JM; Midura RJ; Gudjonsson JE; Ward NL
    J Clin Invest; 2020 Jun; 130(6):3151-3157. PubMed ID: 32155135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role for PAR1 in kallikrein 6-mediated oligodendrogliopathy.
    Burda JE; Radulovic M; Yoon H; Scarisbrick IA
    Glia; 2013 Sep; 61(9):1456-70. PubMed ID: 23832758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype.
    Silini A; Ghilardi C; Ardinghi C; Bernasconi S; Oliva P; Carraro F; Naldini A; Bani MR; Giavazzi R
    Clin Exp Metastasis; 2010; 27(1):43-53. PubMed ID: 20084489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis.
    Blackburn JS; Liu I; Coon CI; Brinckerhoff CE
    Oncogene; 2009 Dec; 28(48):4237-48. PubMed ID: 19734937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion.
    Klucky B; Mueller R; Vogt I; Teurich S; Hartenstein B; Breuhahn K; Flechtenmacher C; Angel P; Hess J
    Cancer Res; 2007 Sep; 67(17):8198-206. PubMed ID: 17804733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines.
    Vandell AG; Larson N; Laxmikanthan G; Panos M; Blaber SI; Blaber M; Scarisbrick IA
    J Neurochem; 2008 Nov; 107(3):855-70. PubMed ID: 18778305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Senescent fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach.
    Kim E; Rebecca V; Fedorenko IV; Messina JL; Mathew R; Maria-Engler SS; Basanta D; Smalley KS; Anderson AR
    Cancer Res; 2013 Dec; 73(23):6874-85. PubMed ID: 24080279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
    Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
    Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kallikrein 6 is a novel molecular trigger of reactive astrogliosis.
    Scarisbrick IA; Radulovic M; Burda JE; Larson N; Blaber SI; Giannini C; Blaber M; Vandell AG
    Biol Chem; 2012 Apr; 393(5):355-67. PubMed ID: 22505518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallikrein-related peptidase 6 induces chemotherapeutic resistance by attenuating auranofin-induced cell death through activation of autophagy in gastric cancer.
    Kim TW; Lee SJ; Kim JT; Kim SJ; Min JK; Bae KH; Jung H; Kim BY; Lim JS; Yang Y; Yoon DY; Choe YK; Lee HG
    Oncotarget; 2016 Dec; 7(51):85332-85348. PubMed ID: 27863404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Important role of kallikrein 6 for the development of keratinocyte proliferative resistance to topical glucocorticoids.
    Kishibe M; Baida G; Bhalla P; Lavker RM; Schlosser B; Iinuma S; Yoshida S; Dudley JT; Budunova I
    Oncotarget; 2016 Oct; 7(43):69479-69488. PubMed ID: 27283773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal cell-associated expression of kallikrein-related peptidase 6 (KLK6) indicates poor prognosis of ovarian cancer patients.
    Seiz L; Dorn J; Kotzsch M; Walch A; Grebenchtchikov NI; Gkazepis A; Schmalfeldt B; Kiechle M; Bayani J; Diamandis EP; Langer R; Sweep FC; Schmitt M; Magdolen V
    Biol Chem; 2012 Apr; 393(5):391-401. PubMed ID: 22505521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KLK6 protease accelerates skin tumor formation and progression.
    Khoury N; Zingkou E; Pampalakis G; Sofopoulos M; Zoumpourlis V; Sotiropoulou G
    Carcinogenesis; 2018 Dec; 39(12):1529-1536. PubMed ID: 30137206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kallikrein-related peptidase 6 orchestrates astrocyte form and function through proteinase activated receptor-dependent mechanisms.
    Yoon H; Radulovic M; Scarisbrick IA
    Biol Chem; 2018 Sep; 399(9):1041-1052. PubMed ID: 29604205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.